Group 16-20 Flashcards
what ia biomea fusion
clinical stage biopharmaceutical company developing oral covalent small molecule inhibitors to treat cancers and metabolic diseases
what is the platform of biomea fusion
built their own fusion system platform ro develop treatments against high value oncogenic drivers
what is coherus bioscience
revenue stage, fully integrated biopharma
what is the platform of coherus biosciences
biosimilar development and immuno-oncology therapeutics
what is alx oncology
clinical stage immuno oncology
what is the platform of alx oncology
next gen cd47 blocking therapeutics
what is immunity bio inc
clinical stage biotech company
what is the platform of immunity bioinc
usage of combination therapies focusing on the enhancement of the immune system to treat various infectious and oncological diseases
what is omni ab
service based biotech company that will partner with pharmaceutical companies to generate thepapeutics
what is the platform of omni ab
Transgenic animal technology to produce human antibodies
* OmniRat, Omnimouse, OmniChicken, OmniTaur, OmniClic, OmniFlic, OmnidAb
what is tango therapeutics
clinical stage biotech committed to discovering novel drug targets and developing next gen of precision meds for the treatment of cancer
what is the platform of tango therapeutics
synthetic lethality for targeting specific tumor suppressor gene loss
what is halozyme therapeutics
clinical stage drug delivery platform biopharmaceutical company
what is the platform for halozyme therapeutics
enhanze drug delivery tech for subcutaneous administration of injected drugs
what is inhibrx
single domain antibody (sdAb) platform foundation to build novel drugs that target a variety of cancers (chondrosarcomas, nonsmall cell lung cancer, head/neck cancer) and alpha 1 antitrypsin (AAT) deficiency, which affects the lungs
what is the platform of inhibrx
core sdAb platform is composed of camelid-derived heavy-chain-only antibodies that are miniaturized into sdAbs
what is indeaya biosciences
precision medecine focused, clinical stage biotech focusing on targeted therapied for cancer treatment
what is the platform of ideaya therapies
Synthetic Lethality (SL), as shown in the figure above, is a drug development strategy that targets specific genetic interactions between two
genes to selectively kill cancer cells by exploiting vulnerabilities created by the loss or mutation of certain genes that occurred exclusively in cancer cells.
what is insmed inc biopharma platform
integration of early-stage research platforms, gene therapy, RNA End-Joining, protein deimmunization,
synthetic rescue and proprietary manufacturing.
what is ironwood
leading gastrointestical focused biopharmaceutical company
what is structure therapeutics
clinical stage global biopharma specializing in orally
available small molecules targeting G-Coupled
Protein Receptors (GPCR
what is aclaris therapeutics
drug discovery and development kinase inhibitor company
what is aclaris platform
Kinase inhibition via cystine residues using analysis technology, KINect
what is meira gtx
clinical stage gene therapy company
what is platform of meiragtx
use gene therapy to customize many vector elements to design a product candidate specific to the disease being targeted (ocular, neurodegenerative and salivary gland diseases) and that allows
precise control of gene expression using proprietary oral small molecule inducers
what is regenxbio
clinical stahe biotech comp
what is platform of regenxbio
NAV® Technology Platform specialized in Adeno-Associated Virus (AVV) Gene Therapy
what is vertex pharmaceuticals
bostion based biopharma company focused on rational drug design
what is the platform of vertex pharma
small molecule drugs-expertise in structure-based drug design - development of high target therapies.
what is ultragenyx pharmaceutical
clinical stage biotech
-Treatments for individuals afflicted with rare and ultra-rare genetic disorders such as X-linked hypophosphatemia (XLH), tumor-induced osteomalacia (TIO), osteogenesis imperfecta and others
what is platform of ultragenyx pharmaceutical
traditional biologics, small molecules, gene therapies, nucleic acid therapies
what is autolus therapeutics
develops car t therapies for cancer patients
what is platform autolus therapeutics
CAR T cell therapy company developing advanced autologous T cell therapies, clinical stage programs for hematological
and solid tumor indications. (Publications: Nature, Molecular Therapy)
what is iovance biotherapeutics
clinical stage biopharmaceutical company with focus on cancer immunotherapiesw
what is the platform of iovance
It is mainly based on tumor infiltrating lymphocytes (TIL) therapy that involves isolating T cells from patient’s tumor, expanding them
ex vivo and re-infusing them into the patient to target and kill cancer cells.
what is sana biotech
Biotechnology company that focuses on engineering cells for hematologic cancers, B-cell
mediated autoimmune diseases, and regenerative medicine
what is sana biotech platform
engineered CAR T cells, primary islet cells, and iPSCs
what is replimune
*Clinical-stage biopharmaceutical company focused on advancing a novel pipeline of cancer immunotherapies centered around oncolytic viruses.
what is replimune platform
Cancer immunotherapies through genetically engineering a proprietary oncolytic virus to enhance tumor specificity and increase therapy safety. Virus then modified with therapeutic transgenes to maximize anti-tumor activity. Designed for unmet cancer needs
